Literature DB >> 15664448

Estrogen receptor independent rapid non-genomic effects of environmental estrogens on [Ca2+]i in human breast cancer cells.

Deirdre E Walsh1, Peter Dockery, Christina M Doolan.   

Abstract

The aim of this study was to identify and characterize an alternative pathway through which environmental estrogenic compounds may mediate their intracellular effects. Three human breast cancer cell lines were employed including MCF-7 cells, which express both ERalpha and ERbeta; MDA-MB-231 cells, which express ERbeta but not ERalpha; and SKBR-3 cells, which express neither ERalpha nor ERbeta. The effect of environmental estrogenic compounds on intracellular calcium ion concentration ([Ca(2+)](i)) was measured and compared to that of 17beta-estradiol (E2). A rapid and maintained increase in [Ca(2+)](i) was observed following the application of nanomolar concentrations of environmental estrogens and E2 regardless of the expression of ERalpha and ERbeta. Removal of extracellular Ca(2+) completely abolished the steroid-induced [Ca(2+)](i) increase. Pre-treatment of cells with the estrogen receptor (ER) antagonist ICI 182,780 had no effect on either basal [Ca(2+)](i) or the steroid-triggered [Ca(2+)](i) response. In summary, we have demonstrated ER independent rapid non-genomic effects of environmental estrogenic compounds, at nanomolar concentrations, on [Ca(2+)](i). The results of this study demonstrate an alternative pathway to explain potent intracellular effects of endocrine disrupting chemicals.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15664448     DOI: 10.1016/j.mce.2004.11.006

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  21 in total

Review 1.  Hormones and endocrine-disrupting chemicals: low-dose effects and nonmonotonic dose responses.

Authors:  Laura N Vandenberg; Theo Colborn; Tyrone B Hayes; Jerrold J Heindel; David R Jacobs; Duk-Hee Lee; Toshi Shioda; Ana M Soto; Frederick S vom Saal; Wade V Welshons; R Thomas Zoeller; John Peterson Myers
Journal:  Endocr Rev       Date:  2012-03-14       Impact factor: 19.871

2.  Bisphenol A activates Maxi-K (K(Ca)1.1) channels in coronary smooth muscle.

Authors:  Shinichi Asano; Johnathan D Tune; Gregory M Dick
Journal:  Br J Pharmacol       Date:  2010-03-19       Impact factor: 8.739

3.  Chapel Hill bisphenol A expert panel consensus statement: integration of mechanisms, effects in animals and potential to impact human health at current levels of exposure.

Authors:  Frederick S vom Saal; Benson T Akingbemi; Scott M Belcher; Linda S Birnbaum; D Andrew Crain; Marcus Eriksen; Francesca Farabollini; Louis J Guillette; Russ Hauser; Jerrold J Heindel; Shuk-Mei Ho; Patricia A Hunt; Taisen Iguchi; Susan Jobling; Jun Kanno; Ruth A Keri; Karen E Knudsen; Hans Laufer; Gerald A LeBlanc; Michele Marcus; John A McLachlan; John Peterson Myers; Angel Nadal; Retha R Newbold; Nicolas Olea; Gail S Prins; Catherine A Richter; Beverly S Rubin; Carlos Sonnenschein; Ana M Soto; Chris E Talsness; John G Vandenbergh; Laura N Vandenberg; Debby R Walser-Kuntz; Cheryl S Watson; Wade V Welshons; Yelena Wetherill; R Thomas Zoeller
Journal:  Reprod Toxicol       Date:  2007-07-27       Impact factor: 3.143

4.  Bisphenol A differently inhibits CaV3.1, Ca V3.2 and Ca V3.3 calcium channels.

Authors:  Pavlovičová Michaela; Karmažínová Mária; Huláková Silvia; Lacinová L'ubica
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2013-10-30       Impact factor: 3.000

5.  Developmental programming: impact of fetal exposure to endocrine-disrupting chemicals on gonadotropin-releasing hormone and estrogen receptor mRNA in sheep hypothalamus.

Authors:  Megan M Mahoney; Vasantha Padmanabhan
Journal:  Toxicol Appl Pharmacol       Date:  2010-06-04       Impact factor: 4.219

6.  Lactogens and estrogens in breast cancer chemoresistance.

Authors:  Gila Idelman; Eric M Jacobson; Traci R Tuttle; Nira Ben-Jonathan
Journal:  Expert Rev Endocrinol Metab       Date:  2011-05

Review 7.  Endocrine-disrupting chemicals: associated disorders and mechanisms of action.

Authors:  Sam De Coster; Nicolas van Larebeke
Journal:  J Environ Public Health       Date:  2012-09-06

Review 8.  Actions of estrogens and endocrine disrupting chemicals on human prostate stem/progenitor cells and prostate cancer risk.

Authors:  Wen-Yang Hu; Guang-Bin Shi; Dan-Ping Hu; Jason L Nelles; Gail S Prins
Journal:  Mol Cell Endocrinol       Date:  2011-09-05       Impact factor: 4.102

9.  ERK/CANP rapid signaling mediates 17β-estradiol-induced proliferation of human breast cancer cell line MCF-7 cells.

Authors:  Guo-Sheng Wang; Yan-Gang Huang; Huan Li; Shi-Jie Bi; Jin-Long Zhao
Journal:  Int J Clin Exp Med       Date:  2014-01-15

Review 10.  Endocrine disruptors and prostate cancer risk.

Authors:  Gail S Prins
Journal:  Endocr Relat Cancer       Date:  2008-06-04       Impact factor: 5.678

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.